Panbela Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Panbela Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2011 to Q3 2024.
  • Panbela Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 4.85M shares, a 62% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 4.85M +1.86M +62% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 4.85M +2.24M +85.9% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 4.85M -11.2M -69.8% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 480K +478K Dec 31, 2023 10-Q 2024-11-14
Q3 2023 3M -17.8M -85.6% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 2.61M -18.2M -87.4% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 16.1M +2.64M +19.6% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 1.74K* -334K Dec 31, 2022 10-K 2024-03-26
Q3 2022 20.8M +7.36M +54.8% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 20.8M +10.7M +106% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 13.4M +3.36M +33.3% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 336K -9.33M -96.5% Dec 31, 2021 10-K 2023-03-16
Q3 2021 13.4M +3.78M +39.2% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 10.1M +3.03M +42.8% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 10.1M +3.46M +52.1% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 9.66M +3.03M +45.7% Dec 31, 2020 10-K 2022-03-24
Q3 2020 9.65M +3.03M +45.7% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 7.07M +1.35M +23.5% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 6.63M +1.56M +30.8% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 6.63M +1.55M +30.6% Dec 31, 2019 10-K 2021-03-25
Q3 2019 6.62M +1.56M +30.9% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 5.72M +662K +13.1% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 5.07M +976K +23.9% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 5.08M +1.24M +32.2% Dec 31, 2018 10-K 2020-03-24
Q3 2018 5.06M +1.39M +37.9% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 5.06M -31.6M -86.2% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 4.09M -32.3M -88.8% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 3.84M +622K +19.3% Dec 31, 2017 10-K 2019-03-22
Q3 2017 3.67M -28.5M -88.6% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 36.7M +4.82M +15.1% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 36.4M +6.5M +21.7% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 3.22M -26.7M -89.2% Dec 31, 2016 10-K 2018-03-21
Q3 2016 32.2M +2.26M +7.56% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 31.9M +30.4M +2098% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 29.9M +28.5M +1964% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 29.9M +24.2M +425% Dec 31, 2015 10-K 2017-03-30
Q3 2015 29.9M +28.4M +1961% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 1.45M 0 0% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 1.45M 0 0% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 5.69M +4.24M +292% Dec 31, 2014 10-K 2016-03-08
Q3 2014 1.45M 0 0% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 1.45M 0 0% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 1.45M 0 0% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 1.45M 0 0% Dec 31, 2013 10-K 2015-03-30
Q3 2013 1.45M Sep 30, 2013 10-Q 2013-11-14
Q2 2013 1.45M Jun 30, 2013 10-Q 2013-08-14
Q1 2013 1.45M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 1.45M 0 0% Dec 31, 2012 10-K 2014-03-28
Q4 2011 1.45M Dec 31, 2011 10-K 2013-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.